We are pleased to invite you to read the selected papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Pediatric Oncology”. The paper list is as follows:

The list of relevant papers can be seen below:

1. “Experiences of Female Childhood Cancer Patients and Survivors Regarding Information and Counselling on Gonadotoxicity Risk and Fertility Preservation at Diagnosis: A Systematic Review”
by Nikita H. Z. Clasen, M. E. Madeleine van der Perk, Sebastian J. C. M. M. Neggers, Annelies M. E. Bos and Marry M. van den Heuvel-Eibrink
Cancers 2023, 15(7), 1946; https://doi.org/10.3390/cancers15071946
Available online: https://www.mdpi.com/2072-6694/15/7/1946

2. “Hyperleukocytosis in Childhood Acute Leukemia: Early Complications and Survival Outcomes”
by Sirinthip Kittivisuit, Nichanan Jongthitinon, Pornpun Sripornsawan, Natsaruth Songthawee, Shevachut Chavananon, Chompoonut Limratchapong, Edward B. McNeil and Thirachit Chotsampancharoen
Cancers 2023, 15(12), 3072; https://doi.org/10.3390/cancers15123072
Available online: https://www.mdpi.com/2072-6694/15/12/3072

3. “Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes”
by Juan Pablo Muñoz, Cristina Larrosa, Saray Chamorro, Sara Perez-Jaume, Margarida Simao, Nazaret Sanchez-Sierra, Amalia Varo, Maite Gorostegui, Alicia Castañeda, Moira Garraus et al.
Cancers 2023, 15(19), 4837; https://doi.org/10.3390/cancers15194837
Available online: https://www.mdpi.com/2072-6694/15/19/4837

4. “Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated”
by Alexandra McLean Stevens, Eric S. Schafer, Minhua Li, Maci Terrell, Raushan Rashid, Hana Paek, Melanie B. Bernhardt, Allison Weisnicht, Wesley T. Smith, Noah J. Keogh et al.
Cancers 2023, 15(4), 1344; https://doi.org/10.3390/cancers15041344
Available online: https://www.mdpi.com/2072-6694/15/4/1344

5. “Targeting the Hedgehog Pathway in Rhabdomyosarcoma”
by Patricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, Gabriela Guillén, Gabriel Gallo-Oller, Guillem Pons, Julia Sansa-Girona, Miguel F. Segura, Josep Sánchez de Toledo, Lucas Moreno et al.
Cancers 2023, 15(3), 727; https://doi.org/10.3390/cancers15030727
Available online: https://www.mdpi.com/2072-6694/15/3/727

6. “Co-Occurrence of Beckwith–Wiedemann Syndrome and Early-Onset Colorectal Cancer”
by Francesco Cecere, Laura Pignata, Bruno Hay Mele, Abu Saadat, Emilia D’Angelo, Orazio Palumbo, Pietro Palumbo, Massimo Carella, Gioacchino Scarano, Giovanni Battista Rossi et al.
Cancers 2023, 15(7), 1944; https://doi.org/10.3390/cancers15071944
Available online: https://www.mdpi.com/2072-6694/15/7/1944

7. “Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients”
by K. L. Juliëtte Schmidt, Noël M. M. Dautzenberg, Peter M. Hoogerbrugge, Caroline A. Lindemans, Stefan Nierkens, Gaby Smits, Rob S. Van Binnendijk, Louis J. Bont and Wim J. E. Tissing
Cancers 2023, 15(9), 2562; https://doi.org/10.3390/cancers15092562
Available online: https://www.mdpi.com/2072-6694/15/9/2562

8. “The Battlefield of Chemotherapy in Pediatric Cancers”
by Letao Bo, Youyou Wang, Yidong Li, John N. D. Wurpel, Zoufang Huang and Zhe-Sheng Chen
Cancers 2023, 15(7), 1963; https://doi.org/10.3390/cancers15071963
Available online: https://www.mdpi.com/2072-6694/15/7/1963

9. “Advancing Pediatric Oncology Rehabilitation: Survey Findings of Health Professionals’ Perceptions of Barriers to Care and a Framework for Action”
by Paula A. Ospina, Lesley Pritchard, David D. Eisenstat and Margaret L. McNeely
Cancers 2023, 15(3), 693; https://doi.org/10.3390/cancers15030693
Available online: https://www.mdpi.com/2072-6694/15/3/693

10. “Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma”
by Silvia Pomella, Sara G. Danielli, Rita Alaggio, Willemijn B. Breunis, Ebrahem Hamed, Joanna Selfe, Marco Wachtel, Zoe S. Walters, Beat W. Schäfer, Rossella Rota et al.
Cancers 2023, 15(10), 2823; https://doi.org/10.3390/cancers15102823
Available online: https://www.mdpi.com/2072-6694/15/10/2823

11. “STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo”
by Kyle A. Rohrer, Heyu Song, Anum Akbar, Yingling Chen, Suravi Pramanik, Phillip J. Wilder, Erin M. McIntyre, Nagendra K. Chaturvedi, Kishor K. Bhakat, Angie Rizzino et al.
Cancers 2023, 15(8), 2239; https://doi.org/10.3390/cancers15082239
Available online: https://www.mdpi.com/2072-6694/15/8/2239

12. “Safety, Feasibility and Efficacy of Lokomat® and Armeo®Spring Training in Deconditioned Paediatric, Adolescent and Young Adult Cancer Patients”
by Morgan Atkinson, Angela Tully, Carol A. Maher, Christopher Innes-Wong, Ray N. Russo and Michael P. Osborn
Cancers 2023, 15(4), 1250; https://doi.org/10.3390/cancers15041250
Available online: https://www.mdpi.com/2072-6694/15/4/1250

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office